Aminex Therapeutics, Inc. is a clinical-stage biotechnology company focused on the development of a novel small molecule combination therapy for the treatment of broad range of cancer indications. Aminex has advanced AMXT 1501 + DFMO through target discovery, patenting, pre-clinical research and now into clinical development for the potential benefit of cancer patients.
View Top Employees from Aminex Therapeutics| Website | http://www.aminextherapeutics.com |
| Revenue | $811000 |
| Funding | $5.6 million |
| Employees | 9 (6 on RocketReach) |
| Founded | 2008 |
| Address | 11335 NE 122nd Way Ste 105, Kirkland, Washington 98034, US |
| Phone | (425) 286-4222 |
| Industry | Biotechnology Research, Manufacturing General, Manufacturing |
| Web Rank | 5 Million |
| Keywords | Aminex Neuroblastoma, Aminex Therapeutics Seattle, Aminex Therapeutics Seattle Career |
| Competitors | Aduro Biotech Europe, BioImmersion, TVAX Biomedical, Inc., Vaxart, Inc., eFFECTOR Therapeutics, Inc. |
| SIC | SIC Code 80 Companies, SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 54171 Companies, NAICS Code 99 Companies, NAICS Code 5417 Companies, NAICS Code 541711 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies |
Looking for a particular Aminex Therapeutics employee's phone or email?
Aminex Therapeutics Questions
The Aminex Therapeutics annual revenue was $811000 in 2024.
Jeff Judson is the Vice President, Strategic Planning of Aminex Therapeutics.
6 people are employed at Aminex Therapeutics.
Aminex Therapeutics is based in Kirkland, Washington.
The NAICS codes for Aminex Therapeutics are [54171, 99, 5417, 541711, 54, 541].
The SIC codes for Aminex Therapeutics are [80, 28, 283].
Top Aminex Therapeutics Employees
-
35+
-
34
-
31
-
ViewNicole Gallegos
Vice President Clinical Operations at Aminex Therapeutics
San Antonio, Texas, United States25+ -
5+3
Related Companies
